Teladoc Health Inc Revenue Growth Rates (TDOC), Current and Historic Growth - CSIMarket
CSIMarket
 


Teladoc Health Inc   (NYSE: TDOC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

TDOC's Revenue Growth by Quarter and Year

Teladoc Health Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TDOC/growth
https://api.csimarket.com/api/v1/companies/TDOC/fundamentals
https://api.csimarket.com/api/v1/companies/TDOC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
TDOC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 605.10
2nd Quarter June 606.93
1st Quarter March 613.85
FY 1,825.88

TDOCs Annual Revenue
Teladoc Health Inc 's Revenue in the fiscal year 2025 $ 2,529.98 millions
Teladoc Health Inc 's Revenue in the fiscal year 2024 $ 2,569.57 millions
Teladoc Health Inc 's Revenue in the fiscal year 2023 $ 2,602.42 millions
Teladoc Health Inc 's Revenue in the fiscal year 2022 $ 2,406.84 millions
Teladoc Health Inc 's Revenue in the fiscal year 2021 $ 2,032.71 millions




TDOC Revenue third quarter 2026 Y/Y Growth Comment
Teladoc Health Inc reported decrease in Revenue in the third quarter 2026 by -3.41% to $ 605.10 millions, from the same quarter in 2025.
The decrease in the third quarter 2026 Teladoc Health Inc 's Revenue compares unfavorably to the Company's average Revenue jump of 47.09%.

Looking into third quarter 2026 results within Healthcare Facilities industry 33 other companies have achieved higher Revenue growth. While Teladoc Health Inc ' s Revenue decline of -3.41% ranks overall at the positon no. 3098 in the third quarter 2026.




TDOC Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -3.41 %
2nd Quarter June -3.95 %
1st Quarter March -2.47 %
FY   -

Financial Statements
Teladoc Health Inc 's third quarter 2026 Revenue $ 605.10 millions TDOC's Income Statement
Teladoc Health Inc 's third quarter 2025 Revenue $ 626.44 millions Quarterly TDOC's Income Statement


TDOC Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -0.3 %
2nd Quarter June -1.13 %
1st Quarter March -4.42 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #34
Healthcare Sector #427
Overall #3098

Revenue Y/Y Growth Statistics
High Average Low
150.93 % 47.09 % -3.95 %
(Dec 31 2022)   (Dec 31 2021)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #34
Healthcare Sector #427
Overall #3098
Revenue Y/Y Growth Statistics
High Average Low
150.93 % 47.09 % -3.95 %
(Dec 31 2022)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Teladoc Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
53.95 % 8.8 % -4.43 %
(Sep 30 2017)  


TDOC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Teladoc Health Inc disclosed decrease in Revenue from the second quarter by -0.3% to $ 605.10 millions, from $ 606.93 millions achived in the previous reporting period.

But that's not important problem, as Teladoc Health Inc 's Revenue generally seem to plunge in this quarter.

Within Healthcare Facilities industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Teladoc Health Inc 's Revenue growth quarter on quarter, overall rank is 1982.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #253
Overall #1982
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #253
Overall #1982
Revenue Q/Q Growth Statistics
High Average Low
53.95 % 8.8 % -4.43 %
(Sep 30 2017)  


TDOC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Teladoc Health Inc disclosed decrease in Revenue from the second quarter by -0.3% to $ 605.10 millions, from $ 606.93 millions achived in the previous reporting period.

But that's not important problem, as Teladoc Health Inc 's Revenue generally seem to plunge in this quarter.

Within Healthcare Facilities industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Teladoc Health Inc 's Revenue growth quarter on quarter, overall rank is 1982.


Teladoc Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 2,468.14
Y / Y Revenue Growth (TTM) -2.38 %
Year on Year Revenue Growth Overall Ranking # 2854
Seqeuential Revenue Change (TTM) -0.86 %
Seq. Revenue Growth (TTM) Overall Ranking # 2661


Cumulative Revenue growth Comment
Teladoc Health Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -2.38% year on year, at Sep 30 2026 compare to the -2.08% decrease at Jun 30 2026. If the Teladoc Health Inc 's fiscal year would end at Sep 30 2026, annual Revenue would be $2,468 millions.

In the Healthcare sector 403 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1828 to 2854.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 28
Healthcare Sector # 404
Overall # 2854

Revenue TTM Y/Y Growth Statistics
High Average Low
127.42 %
47.07 %
-2.57 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 381
S&P 500 # 2661
Cumulative Revenue growth Comment
Teladoc Health Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -2.38% year on year, at Sep 30 2026 compare to the -2.08% decrease at Jun 30 2026. If the Teladoc Health Inc 's fiscal year would end at Sep 30 2026, annual Revenue would be $2,468 millions.

In the Healthcare sector 403 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1828 to 2854.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 28
Healthcare Sector # 404
Overall # 2854

Revenue TTM Y/Y Growth Statistics
High Average Low
127.42 %
47.07 %
-2.57 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 381
S&P 500 # 2661




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TDOC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Viatris Inc -0.28%$ -0.277 millions
Zoetis Inc -0.38%$ -0.375 millions
Pfizer Inc-0.43%$ -0.426 millions
Standard Biotools Inc -0.51%$ -0.508 millions
Globus Medical Inc -0.69%$ -0.693 millions
Conmed Corporation-0.70%$ -0.701 millions
Surgery Partners Inc -0.75%$ -0.755 millions
Myriad Genetics Inc -1.03%$ -1.025 millions
Lensar Inc -1.29%$ -1.292 millions
Fortrea Holdings Inc -1.40%$ -1.397 millions
Immunocore Holdings Plc-1.42%$ -1.419 millions
Pacira Biosciences inc -1.59%$ -1.595 millions
Organon and Co -1.75%$ -1.748 millions
Teva Pharmaceutical Industries Limited-1.90%$ -1.897 millions
Skinhealth Systems Inc -2.07%$ -2.071 millions
Charles River Laboratories International inc -2.20%$ -2.201 millions
Inogen Inc -2.40%$ -2.399 millions
Novavax inc -3.05%$ -3.048 millions
Seer Inc -3.14%$ -3.139 millions
Teladoc Health Inc -3.41%$ -3.406 millions
Cg Oncology Inc -3.72%$ -3.721 millions
Treace Medical Concepts Inc -3.91%$ -3.905 millions
Sarepta Therapeutics Inc -4.51%$ -4.509 millions
Pacific Health Care Organization Inc-4.69%$ -4.689 millions
Tela Bio Inc -5.06%$ -5.058 millions
Perrigo Company Plc-5.22%$ -5.225 millions
Heron Therapeutics Inc -5.49%$ -5.493 millions
Zai Lab Limited-6.79%$ -6.794 millions
Solventum Corporation-7.01%$ -7.013 millions
Janux Therapeutics Inc -7.11%$ -7.110 millions


About Teladoc Health Inc Revenue Growth Rates (TDOC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Teladoc Health Inc (CIK 1477449).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477449-26-000052
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Teladoc Health Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.